Harvard Medical School Update on POCT

We appreciate that there has been a lack of clarity even amongst experienced clinicians, on how to best use rapid antibody test kits such as Cellex. We have as part of our team, a number of Harvard Medical School Alumni, including the CEO and Founder of Cellex - Dr. James Li and our very own Medicision Co-Founder - Dr. Joshua Chou. There is no doubt that there is a role that such tests can play, especially when it comes to screening populations and building a database to assist in monitoring and tracking COVID-19. This Harvard Medical School update my colleagues received, provides an informative overview of their public health use and place in assisting in a holistic COVID-19 strategy https://hms.harvard.edu/news/seek-test-treat?utm_source=linkedin&utm_medium=social&utm_campaign=hms-linkedin-general